Susquehanna International Group, LLP Kymera Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 23,714 shares of KYMR stock, worth $969,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,714

Previous 17,792 33.28%

Holding current value

$969,665

Previous $531,000 111.3%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $178,607 - $310,312	5,922 Added 33.28%	23,714 $1.12 Million
Q2 2024 Aug 15, 2024	SELL	$29.85 - $39.42 $233,994 - $309,013	-7,839 Reduced 30.58%	17,792 $531,000
Q1 2024 May 07, 2024	SELL	$22.9 - $43.57 $106,393 - $202,426	-4,646 Reduced 15.34%	25,631 $1.03 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $654,217 - $1.6 Million	-59,637 Reduced 66.33%	30,277 $770,000
Q3 2023 Nov 14, 2023	SELL	$13.9 - $23.88 $74,253 - $127,566	-5,342 Reduced 5.61%	89,914 $1.25 Million
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $505,769 - $788,458	22,579 Added 31.07%	95,256 $2.19 Million
Q1 2023 May 16, 2023	BUY	$24.84 - $38.75 $1.39 Million - $2.16 Million	55,867 Added 332.34%	72,677 $2.15 Million
Q4 2022 Feb 14, 2023	SELL	$19.57 - $30.92 $947,070 - $1.5 Million	-48,394 Reduced 74.22%	16,810 $419,000
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $1.36 Million - $2.23 Million	65,204 New	65,204 $1.42 Million
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $469,681 - $1.41 Million	-33,240 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $210,352 - $385,428	-5,959 Reduced 15.2%	33,240 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $743,409 - $976,516	14,895 Added 61.29%	39,199 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $317,917 - $443,355	6,651 Added 37.68%	24,304 $1.43 Million
Q2 2021 Aug 11, 2021	SELL	$31.08 - $51.95 $645,718 - $1.08 Million	-20,776 Reduced 54.06%	17,653 $856,000
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $1.37 Million - $3.28 Million	38,429 New	38,429 $1.49 Million

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.24B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Kymera Therapeutics, Inc. Transaction History